GBUK Group Revenue and Competitors
Estimated Revenue & Valuation
- GBUK Group's estimated annual revenue is currently $30.9M per year.
- GBUK Group's estimated revenue per employee is $251,000
Employee Data
- GBUK Group has 123 Employees.
- GBUK Group grew their employee count by 28% last year.
GBUK Group Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 338 | 10% | N/A | N/A |
#2 | $376.7M | 938 | 28% | $974.7M | N/A |
#3 | $1M | 4 | -20% | N/A | N/A |
#4 | $258.8M | 1031 | 18% | N/A | N/A |
#5 | $136M | 542 | 8% | N/A | N/A |
#6 | $20.3M | 81 | 11% | N/A | N/A |
#7 | $44.7M | 178 | 13% | N/A | N/A |
#8 | $32.9M | 131 | 9% | N/A | N/A |
#9 | $78.3M | 312 | -8% | N/A | N/A |
#10 | $34.4M | 137 | 11% | N/A | N/A |
What Is GBUK Group?
GBUK is an award winning specialist in the provision of enteral feeding, critical care and patient handling products and services. The group has an extensive portfolio of own IP and select 3rd party medical products, focused on both single-use and single patient use. The GBUK Group currently supplies every NHS Trust in the UK and is rapidly expanding, both beyond the NHS and beyond the UK.
keywords:N/AN/A
Total Funding
123
Number of Employees
$30.9M
Revenue (est)
28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
GBUK Group News
A team of volunteer hauliers from the UK, Poland and Ukraine have made the ... Rocialle Healthcare, GBUK Group, Intersurgical, Timesco,...
... encountered thanks to a group of expert and culturally diverse experts. ... Jorgensen Labs; B. Braun Interventional; Chimed; Obex Medical; GBUK Group...
Circle Health Group has committed to continue the weekly delivery programme for ... Rocialle Healthcare, GBUK Group, Intersurgical, Timesco,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $17.8M | 123 | N/A | N/A |
#2 | $7.5M | 123 | 9% | N/A |
#3 | $30.3M | 123 | -4% | N/A |
#4 | $17.8M | 123 | 19% | N/A |
#5 | $7.5M | 123 | 3% | N/A |